INSTITUTE FOR SYSTEMS BIOLOGY
SEATTLE, WA
What changed
NIH U54 · $2.6M · Spatiotemporal Tumor Analytics for Guiding Sequential Targeted-Inhibitor: Immunotherapy Combinations (ST-Analytics)
10mo agoGrant renewalSep 12, 2025Source filing (opens the source filing in a new tab)
Momentum
Momentum 46 out of 100, unchanged since the last recompute.
Some recent activity, at a steady rate.
Runway (estimate)
No disclosed raise on file, so there is nothing to model from.
Stage
Grant-only
The furthest-along thing in the public record. Not a projection.
Runway is an estimate: the last disclosed raise (SEC Form D) minus a modeled burn rate for the company’s stage and therapeutic area. It is not a disclosure, and companies routinely raise non-dilutive money we can’t see. How this is calculated.
Grant to raise
Every record Biodatica has resolved onto this company, newest first, each linked to the filing it came from. Where a source publishes no stable deep link for a record, the identifier is shown so you can look it up yourself.
- Grant
U54 · $2.6M · non-dilutive
Sep 22, 2022INSTITUTE FOR SYSTEMS BIOLOGY · PI HEATH, JAMES R. · NCI · award ends Aug 31, 2027 · Spatiotemporal Tumor Analytics for Guiding Sequential Targeted-Inhibitor: Immunotherapy Combinations (ST-Analytics)
NIH RePORTER · NIH RePORTER 11191397 (opens the source filing in a new tab)
- Grant
U54 · $414k · non-dilutive
Sep 22, 2022INSTITUTE FOR SYSTEMS BIOLOGY · PI HEATH, JAMES R. · NCI · award ends Aug 31, 2027 · Administrative Core
NIH RePORTER · NIH RePORTER 11191414 (opens the source filing in a new tab)
- Grant
U54 · $801k · non-dilutive
Sep 22, 2022INSTITUTE FOR SYSTEMS BIOLOGY · PI HEATH, JAMES R. · NCI · award ends Aug 31, 2027 · PROJECT 1: TIME-Based Spatiotemporal Cancer Immunograms Predictive for Immunotherapy-Targeted Therapy Sequential Combinations
NIH RePORTER · NIH RePORTER 11191418 (opens the source filing in a new tab)
- Grant
R01 · $524k · non-dilutive
Sep 16, 2021INSTITUTE FOR SYSTEMS BIOLOGY · PI HEATH, JAMES R. · NCI · award ends Jun 30, 2027 · Nano and biomolecular engineered technologies for neoantigen-specific T cell capture and characterization
NIH RePORTER · NIH RePORTER 11121834 (opens the source filing in a new tab)
Biodatica publishes impersonal research shown identically to every subscriber. This dossier is informational only, it is not investment advice, and the momentum and runway figures are estimates derived from public filings. The underlying records are U.S. government works. Disclosures · Data sources